DK302287D0 - Ligander og fremgangsmaader til foroegelse af b-celler-proliferation - Google Patents

Ligander og fremgangsmaader til foroegelse af b-celler-proliferation

Info

Publication number
DK302287D0
DK302287D0 DK302287A DK302287A DK302287D0 DK 302287 D0 DK302287 D0 DK 302287D0 DK 302287 A DK302287 A DK 302287A DK 302287 A DK302287 A DK 302287A DK 302287 D0 DK302287 D0 DK 302287D0
Authority
DK
Denmark
Prior art keywords
ligands
procedures
increasing
cell proliferation
proliferation
Prior art date
Application number
DK302287A
Other languages
English (en)
Other versions
DK173940B1 (da
DK302287A (da
Inventor
Jeffrey A Ledbetter
Edward A Clark
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of DK302287D0 publication Critical patent/DK302287D0/da
Publication of DK302287A publication Critical patent/DK302287A/da
Application granted granted Critical
Publication of DK173940B1 publication Critical patent/DK173940B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6849—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a receptor, a cell surface antigen or a cell surface determinant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0635—B lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/74—Inducing cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK198703022A 1986-06-13 1987-06-12 Ligander og fremgangsmåder til forøgelse af B-celle-proliferation samt B-celle-overfladeantigen Bp50 DK173940B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87388486A 1986-06-13 1986-06-13
US87388486 1986-06-13

Publications (3)

Publication Number Publication Date
DK302287D0 true DK302287D0 (da) 1987-06-12
DK302287A DK302287A (da) 1987-12-14
DK173940B1 DK173940B1 (da) 2002-03-04

Family

ID=25362524

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198703022A DK173940B1 (da) 1986-06-13 1987-06-12 Ligander og fremgangsmåder til forøgelse af B-celle-proliferation samt B-celle-overfladeantigen Bp50

Country Status (22)

Country Link
JP (1) JPH0762040B2 (da)
KR (1) KR910004100B1 (da)
AT (1) AT398437B (da)
AU (1) AU617087B2 (da)
BE (1) BE1000587A4 (da)
CA (1) CA1338781C (da)
CH (1) CH676600A5 (da)
CY (1) CY1681A (da)
DE (1) DE3719398C2 (da)
DK (1) DK173940B1 (da)
FR (1) FR2607136B1 (da)
GB (1) GB2191494B (da)
GR (1) GR870930B (da)
HK (1) HK10293A (da)
IE (1) IE60486B1 (da)
IL (1) IL82841A (da)
IT (1) IT1208649B (da)
LU (1) LU86919A1 (da)
NL (1) NL195022C (da)
PT (1) PT85073B (da)
SE (1) SE504675C2 (da)
SG (1) SG118992G (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506126A (en) * 1988-02-25 1996-04-09 The General Hospital Corporation Rapid immunoselection cloning method
US5397703A (en) 1992-07-09 1995-03-14 Cetus Oncology Corporation Method for generation of antibodies to cell surface molecules
CO4600681A1 (es) * 1996-02-24 1998-05-08 Boehringer Ingelheim Pharma Composicion farmaceutica para la modulacion inmunitaria

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443427A (en) * 1982-06-21 1984-04-17 Sidney Farber Cancer Institute, Inc. Monoclonal antibody
EP0117705A3 (en) * 1983-02-24 1985-09-25 The Regents Of The University Of California Monoclonal antibody specific for monocytes and blast cells
FR2547731A1 (fr) * 1983-06-27 1984-12-28 Centre Nat Rech Scient Immunotoxine antitumorale, preparations pharmaceutiques la contenant et son utilisation in vitro
US4585742A (en) * 1983-12-14 1986-04-29 Dana-Farber Cancer Institute, Inc. Monoclonal antibody with specificity to human small cell carcinoma and use thereof

Also Published As

Publication number Publication date
ATA151387A (de) 1994-04-15
PT85073B (pt) 1990-07-31
GB2191494B (en) 1990-08-22
SE504675C2 (sv) 1997-04-07
DK173940B1 (da) 2002-03-04
IT1208649B (it) 1989-07-10
NL8701371A (nl) 1988-01-04
KR880000582A (ko) 1988-03-28
AT398437B (de) 1994-12-27
SE8702463L (sv) 1987-12-14
GR870930B (en) 1987-12-16
IT8720899A0 (it) 1987-06-12
JPS6480299A (en) 1989-03-27
CA1338781C (en) 1996-12-10
CH676600A5 (da) 1991-02-15
SE8702463D0 (sv) 1987-06-12
LU86919A1 (fr) 1989-03-08
DE3719398A1 (de) 1988-01-28
IL82841A (en) 1992-11-15
FR2607136A1 (fr) 1988-05-27
GB8713650D0 (en) 1987-07-15
CY1681A (en) 1993-10-10
AU617087B2 (en) 1991-11-21
KR910004100B1 (ko) 1991-06-22
GB2191494A (en) 1987-12-16
JPH0762040B2 (ja) 1995-07-05
BE1000587A4 (fr) 1989-02-14
IL82841A0 (en) 1987-12-20
AU7421487A (en) 1987-12-17
NL195022C (nl) 2003-06-18
IE60486B1 (en) 1994-07-27
DE3719398C2 (de) 1996-03-28
PT85073A (en) 1987-07-01
FR2607136B1 (fr) 1989-09-15
HK10293A (en) 1993-02-19
DK302287A (da) 1987-12-14
IE871563L (en) 1987-12-13
SG118992G (en) 1993-01-29

Similar Documents

Publication Publication Date Title
DK302983D0 (da) Phenyl alpha-acyloxyacetamid-derivater og fremgangsmader til fremstilling deraf
DK497682A (da) Fremgangsmaade til fremstilling af 7-oxabicycloheptan- og 7-oxabicycloheptenprostaglandinanaloge
DK276683A (da) Carbapenemer og fremgangsmaade til fremstilling deraf
DK581688D0 (da) L-tyrosinderivater og fremgangsmaade til fremstilling af samme
DK549087D0 (da) Gangliosidbeslaegtede forbindelser og fremgangsmaade til fremstilling af samme
DK302287D0 (da) Ligander og fremgangsmaader til foroegelse af b-celler-proliferation
DK258483A (da) Skaal til madlavning med laag og daeksel
DK343183A (da) Ketoquinoliner og fremgangsmaade til fremstilling deraf
DK443487D0 (da) Multistik og fremgangsmaade og maskine til fremstilling af samme
DK102387D0 (da) Fremgangsmaade til fremstilling af biscarbamater og nye biscarbamater
DK509587A (da) Fremgangsmaade til inhibering af genekspression
DK403183A (da) Impraegneringsmiddel for broed og fremgangsmaade til fremstilling af samme
DK120886D0 (da) Kredsloebsarrangement og fremgangsmaade til fremstilling af samme
DK361387A (da) Fremgangsmaade til fremstilling af piperidinopyrimidin
DK135187D0 (da) Fremgangsmaade til separering af l-leucin og l-isoleusin
DK151640C (da) Fremgangsmaade til fremstilling af forbindelser med carcinostatisk og immunostimulerende virkning
DK422284A (da) Fremgangsmaade og indretning til luftning af maskinrum
DK508689A (da) Organofluorider af tin og fremgangsmaade til fremstilling heraf
DK350288A (da) Fremgangsmaade til fremstilling af n-epoxypropyllactamer
DK464387D0 (da) Fastgoerelsesorgan og fremgangsmaade til fremstilling af dette
DK674787A (da) Herbicidkomposition og fremgangsmaade til anvendelse af samme
DK987D0 (da) Fremgangsmaade til fremstilling af tetrachlorpyri- din
PT86126A (pt) Fogao de gaz
DK216585D0 (da) Beta-carbolin-3-oxadiazolylderivater og fremgangsmaade til fremstilling af samme
DK242583D0 (da) Trans-d,1-1-alkyl-6-alkoxyoctahydroquinoliner og fremgangsmade til fremstilling deraf

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired